跳至主要内容
临床试验/NCT01505751
NCT01505751已完成不适用

The Association of G9a Protein and the Outcome of Patients With Cervical Cancer

Far Eastern Memorial Hospital1 个研究点 分布在 1 个国家目标入组 69 人开始时间: 2012年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
69
试验地点
1
主要终点
determine whether G9a protein is a risk factor of overall survival of patients with cervical cancer

研究概览

简要总结

G9a protein was approved to be highly associated with recurrence of breast cancer, gastric cancer, hepatocellular cancer, prostate cancer and lung cancer. Therefore, the aim of this study was to clarify the association and G9a protein and cervical cancer by analyzing the immunohistochemical staining of G9a protein to the histopathologic specimen of cervical cancer and clinical data.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
20 Years 至 99 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • cases with cervical cancer

排除标准

  • 未提供

结局指标

主要结局

determine whether G9a protein is a risk factor of overall survival of patients with cervical cancer

时间窗: From the date of primary treatment until the date of death from any cause or the date of last follow-up, whichever came first, assessed up to 100 months

次要结局

  • determine whether G9a protein is a risk factor of progression-free survival of patients with cervical cancer(From the date of primary treatment until the date of first documented progression or last follow-up, whichever came first, assessed up to 100 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sheng-Mou Hsiao

Chief, Department of Obstetrics & Gynecology

Far Eastern Memorial Hospital

研究点 (1)

Loading locations...

相似试验